Dr Andy Racher is the Director of Commercial Operations at SynGenSys Ltd. With over four decades in the biotech sector, including a distinguished 20-year tenure at Lonza Biologics, Andy has a wealth of experience covering cell engineering, expression systems, cell line and process development, plus the design and support of cGMP manufacturing process. Andy is now leveraging his extensive industry expertise to turn cutting edge advancements in protein expression technologies into commercial reality.